Funding for this research was provided by:
Teva Pharmaceutical Industries
Received: 22 June 2020
Accepted: 13 August 2020
First Online: 21 September 2020
Ethics approval and consent to participate
: As part of the original study, all patients provided written informed consent and the trial was approved by all relevant review bodies. Because the subgroup analyses used existing data from the primary study, additional consent was not required.
: Not applicable.
: SDS provides consultation to Abide Therapeutics, Allergan, Amgen, Avanir, Biohaven, Cefaly, Curelator, Inc., Dr. Reddy’s Laboratories, Egalet Corporation, GlaxoSmithKline Consumer Health Holdings, LLC, eNeura Inc., electroCore Medical, LLC, Impel NeuroPharma, Inc., Lilly USA, LLC, Medscape, LLC, Novartis, Inc., Satsuma Pharmaceuticals, Supernus Pharmaceuticals, Inc., Teva Pharmaceuticals, Theranica, and Trigemina, Inc. JMC, MJS, and RY are employees of Teva Branded Pharmaceutical Products R&D, Inc. (USA). SA provides consultation for Allergan, Amgen, Promius, Supernus, and Novartis. ZK provides consultation to Allergan, Novartis, Eli Lilly, and Teva Pharmaceuticals.